Natera is a genetic testing company that specializes in non-invasive prenatal testing and other genetic analysis services. Founded in 2004, the company has established itself as a leader in the field of genetic testing, providing advanced diagnostic solutions for reproductive health, oncology, and other medical applications. Natera's flagship product, Panorama, is a non-invasive prenatal test that analyzes fetal DNA in a pregnant woman's bloodstream to detect genetic disorders and chromosomal abnormalities. The company's testing services are designed to provide accurate and reliable results, empowering healthcare providers and patients to make informed decisions about pregnancy, cancer treatment, and other medical conditions. With a strong commitment to innovation and customer satisfaction, Natera has become a trusted partner for healthcare providers and patients worldwide.